Status:
COMPLETED
Pharmacokinetic of Posaconazole in Critically Ill Patients
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Therapeutic Drug Monitoring
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial.
Detailed Description
The posaconazole pharmacokinetic in critically ill patients will be studied in a prospective, non-interventional, monocentric observational trial. Plasma specimens will be retrieved on consecutive day...
Eligibility Criteria
Inclusion
- treatment with intravenous posaconazole
- critically ill patient
- written declaration of consent
Exclusion
- \- no declaration of consent
Key Trial Info
Start Date :
February 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05275179
Start Date
February 11 2021
End Date
November 1 2022
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246